Edward R. Conner - 01 Aug 2025 Form 3 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Medical Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Edward R. Conner
Issuer symbol
ARDX
Transactions as of
01 Aug 2025
Net transactions value
$0
Form type
3
Filing time
17 Oct 2025, 18:17:47 UTC
Previous filing
17 Jan 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Conner Edward R. Chief Medical Officer C/O ARDELYX, INC., 400 FIFTH AVENUE, SUITE 210, WALTHAM /s/ Elizabeth Grammer, Attorney-in-Fact for Edward R. Conner 17 Oct 2025 0001691265

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ARDX Common Stock 302,260 01 Aug 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ARDX Stock Option (Right to Buy) 01 Aug 2025 Common Stock 463,268 $5.21 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.
F2 Twenty Five Percent (25%) of the shares subject to the option vest on August 8, 2026 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Remarks:

Exhibit 24.1 - Power of Attorney